ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

General Practice

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

27,351Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 95

$1.37M Total Retail Price of All Prescriptions

Rank: 2 out of 95

903 Patients Receiving at Least One Drug in Part D
70%Patients 65 Years and Older
57% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 903 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

11% of this provider’s 903 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

3% of this provider’s 20,484 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
FUROSEMIDE 1,138 959 1 5
SIMVASTATIN 1,078 849 2 1
LISINOPRIL 962 710 3 3
OMEPRAZOLE 826 616 4 4
LEVOTHYROXINE SODIUM 777 607 5 2
METFORMIN HCL 769 581 6 9
AMLODIPINE BESYLATE 760 672 7 6
METOPROLOL TARTRATE 566 484 8 7
AZITHROMYCIN 527 338 9 24
METOPROLOL SUCCINATE 500 450 10 13
HYDROCODONE-ACETAMINOPHEN 480 184 S3 11 10
TRAMADOL HCL 436 204 12 17
POTASSIUM CHLORIDE 408 340 13 15
WARFARIN SODIUM 400 348 14 8
NEXIUM 386 249 15 29
ATORVASTATIN CALCIUM 385 322 16 11
ZOLPIDEM TARTRATE 354 200 17 22
CITALOPRAM HBR 326 232 18 16
HYDROCHLOROTHIAZIDE 320 253 19 14
CLOPIDOGREL 300 257 20 21
PANTOPRAZOLE SODIUM 275 209 21 23
ISOSORBIDE MONONITRATE ER 265 224 22 31
CRESTOR 259 214 23 28
GABAPENTIN 259 200 23 20
PLAVIX 250 224 25 34
ALLOPURINOL 210 132 26 30
CIPROFLOXACIN HCL 208 171 27 52
CLONIDINE HCL 203 160 28 72
OXYCODONE-ACETAMINOPHEN 202 130 S2 29 41
ATENOLOL 188 145 30 12
LEVEMIR FLEXPEN 184 140 31 149
SERTRALINE HCL 178 114 32 18
AMOXICILLIN 174 102 33 53
LOSARTAN POTASSIUM 171 130 34 35
PEN NEEDLE 171 133 34 172
LISINOPRIL-HYDROCHLOROTHIAZIDE 170 120 36 55
RANITIDINE HCL 168 115 37 38
TAMSULOSIN HCL 166 151 38 27
LIPITOR 166 139 38 87
KLOR-CON M20 166 156 38 40
CYCLOBENZAPRINE HCL 153 89 R 41 116
PRAVASTATIN SODIUM 151 131 42 26
GLYBURIDE 147 129 R 43 51
PREDNISONE 147 86 43 44
SPIRONOLACTONE 142 127 45 88
CLOTRIMAZOLE-BETAMETHASONE 141 106 46 80
CARVEDILOL 140 129 47 33
ADVAIR DISKUS 136 108 48 53
DONEPEZIL HCL 131 131 49 19
DIOVAN 131 122 49 25
PROAIR HFA 124 54 51 81
LOSARTAN-HYDROCHLOROTHIAZIDE 123 83 52 89
BYSTOLIC 122 107 53 65
RAMIPRIL 120 119 54 64
MELOXICAM 116 74 55 84
GLYBURIDE-METFORMIN HCL 112 101 R 56 173
OXYCODONE HCL 112 32 S2 56 75
TRICOR 110 76 58 118
LANTUS SOLOSTAR 110 82 58 201
GLYBURIDE MICRONIZED 109 103 R 60 170
NOVOLOG FLEXPEN 105 63 61 205
FENTANYL 104 61 S2 62 49
CEPHALEXIN 100 78 63 82
PAROXETINE HCL 99 56 64 57
DICLOFENAC SODIUM 98 66 65 145
AMITRIPTYLINE HCL 97 77 R 66 99
DILTIAZEM 24HR ER 96 68 67 105
GLIMEPIRIDE 95 79 68 47
ALENDRONATE SODIUM 95 83 68 37
DETROL LA 95 83 68 133
ENALAPRIL MALEATE 93 93 71 68
DIGOXIN 93 89 71 32
LANTUS 93 68 71 61
FINASTERIDE 92 92 74 76
VERAPAMIL ER 90 80 75 100
CELEBREX 89 72 76 48
VENLAFAXINE HCL ER 88 36 77 83
JANTOVEN 85 85 78 130
THEOPHYLLINE ANHYDROUS 85 73 78 218
INSULIN SYRINGE 85 71 78 129
DILTIAZEM 24HR CD 84 79 81 110
FENOFIBRATE 84 72 81 109
JANUVIA 83 68 83 70
PHENYTOIN SODIUM EXTENDED 81 45 84 119
MIRTAZAPINE 78 64 85 56
FLUTICASONE PROPIONATE 78 65 85 62
POLYETHYLENE GLYCOL 3350 77 69 87 43
ESCITALOPRAM OXALATE 77 67 87 45
LEVOFLOXACIN 74 58 89 106
VENTOLIN HFA 73 23 90 98
SULFAMETHOXAZOLE-TRIMETHOPRIM 72 55 91 107
FLUOXETINE HCL 69 46 92 73
ZETIA 69 45 92 58
INDOMETHACIN 69 52 R 92 229
TRIAMTERENE-HCTZ 69 60 92 86
NAPROXEN 67 42 96 103
GLIPIZIDE XL 66 27 97 93
LEVEMIR 64 64 98 150
COMBIVENT 64 51 98 137
NABUMETONE 63 57 100 239
LABETALOL HCL 63 52 100 196
MULTAQ 63 63 100 239
SINGULAIR 62 55 103 136
JANUMET 61 52 104 145
HYDRALAZINE HCL 60 49 105 141
AMOX TR-POTASSIUM CLAVULANATE 60 26 105 246
LAMOTRIGINE 60 19 105 128
SYNTHROID 59 53 108 36
OXYCODONE HCL-ACETAMINOPHEN 59 0 S2 108 90
VOLTAREN 57 44 110 199
OLANZAPINE 57 40 110 140
ACETAMINOPHEN-CODEINE 57 11 S3 110 96
METOCLOPRAMIDE HCL 57 55 110 135
NIASPAN 56 25 114 173
PROPRANOLOL HCL 55 51 115 115
SEROQUEL 54 45 116 158
IBUPROFEN 54 35 116 79
TRAMADOL HCL-ACETAMINOPHEN 53 49 118 260
KLOR-CON 10 53 53 118 200
BENICAR HCT 53 42 118 114
OXYBUTYNIN CHLORIDE ER 52 38 121 160
TRAZODONE HCL 51 12 122 77
BUTALBITAL COMPOUND-CODEINE 51 0 S3 R 122 265
DIPHENOXYLATE-ATROPINE 50 21 124 268
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 9, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.